Catheter-directed thrombolysis for acute limb ischemia

Area of Science:

• Vascular Surgery
• Interventional Radiology
• Cardiology

Background:

• Acute limb ischemia (ALI) is a critical condition with significant morbidity and mortality.
• Key causes include in situ thrombosis, bypass graft thrombosis, and embolic occlusion.
• Management strategies are dictated by ALI severity and patient comorbidities.

Purpose of the Study:

• To review the etiology of acute arterial occlusion.
• To outline clinical triage for patients with ALI.
• To discuss catheter-directed thrombolysis (CDT) techniques, agents, devices, and outcomes.

Main Methods:

• Review of literature on ALI etiology and management.
• Analysis of clinical triage protocols for ALI patients.
• Examination of catheter-directed thrombolysis (CDT) techniques, including guide wire methods, pharmacological agents, and devices.
• Evaluation of CDT efficacy and complication rates.

Main Results:

• CDT is the preferred treatment for mild ALI (Rutherford categories I and IIa) without contraindications.
• Severe ALI (Rutherford category IIb) typically requires emergent revascularization.
• CDT can be a viable option for severe ALI if operative risks are higher.
• CDT demonstrates efficacy in saving limbs and lives, despite potential limitations and complications.

Conclusions:

• Catheter-directed thrombolysis is a crucial intervention for acute limb ischemia.
• Appropriate patient selection and technique are vital for successful CDT outcomes.
• CDT represents an important therapeutic option in the management of acute limb ischemia, balancing risks and benefits against traditional surgery.